Fox 2 news report features Dr. Eva Feldman and a stem cell trial patient
The Detroit affiliate of Fox News recently aired an interview with Dr. Eva Feldman and others associated with the groundbreaking trial of a stem cell therapy for ALS. Dr. Feldman is the principal investigator of the trial, which recently received FDA approval to move to Phase 2.
Click here to watch the Fox 2 Detroit video.
11 Taubman Scholars named to "Best Doctors in America" list
They're among 493 U-M physicians to receive the honor from their peers
Click here for the list.
Renowned diabetes expert to speak at U-M
David M. Nathan, M.D., of Harvard University to deliver two lectures April 18
Click here for details
U-M offers new early detection prostate cancer test
Research by Taubman Scholar Dr. Arul Chinnaiyan has let to the development of a new test for prostate cancer that is far more accurate than the standard PSA test, the University of Michigan has announced.
Click here to read more.
news & events
New Taubman Prize trophy debuts
The new trophy for the Taubman Prize for Excellence in Translational Medical Research, which was designed in consultation with institute founder Mr. A. Alfred Taubman, was presented at the institute's Oct. 11 symposium. The modern sculpture was created using a novel 3D printing technique.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.